✦ LIBER ✦

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors

✍ Scribed by Matthew G. Fury; Lee M. Krug; Christopher G. Azzoli; Sunil Sharma; Nancy Kemeny; Nian Wu; Mark G. Kris; Naiyer A. Rizvi

Publisher: Springer
Year: 2005
Tongue: English
Weight: 207 KB
Volume: 57
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-0080-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

✍ A. S. T. Planting; P. Sonneveld; A. van der Gaast; A. Sparreboom; M. E. L. van d 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 253 KB

A phase I study of Triapine®in combinati

A phase I study of Triapine®in combination with doxorubicin in patients with advanced solid tumors

✍ William R. Schelman; Sherry Morgan-Meadows; Rebecca Marnocha; Fred Lee; Jens Eic 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 364 KB

Phase I clinical trial of bortezomib in

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi

Sunitinib in combination with docetaxel

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

✍ Francisco Robert; Alan Sandler; Joan H. Schiller; Glenn Liu; Karen Harper; Lev V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

A phase I trial of gemcitabine in combin

A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

✍ William Schelman; Sherry Morgan-Meadows; Howard Bailey; Kyle Holen; James P. Tho 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 325 KB

Sunitinib in combination with paclitaxel

Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results

✍ Elisabeth I. Heath; George R. Blumenschein; Roger B. Cohen; Patricia M. LoRusso; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 210 KB